血清胃泌素释放肽前体在小细胞肺癌诊断和分期中的临床意义

高振远; 欧毅梅; 张竞竞; 张浩然; 毕明宏; 高振远; 欧毅梅; 张竞竞; 张浩然; 毕明宏

doi:10.13898/j.cnki.issn.1000-2200.2016.01.009

[1]

白晓雪,张艳蓓. 肺癌肿瘤标志物检测的研究现状[J]. 临床肺科杂志,2011,16(2):259.

[2]

张荣华,郑加荣,陈佳佳. 血清肿瘤标志物联合检测对肺癌的临床意义[J]. 中国实用医刊,2011,38(7):28.

[3]

MCDONALD TJ,NILSSON G,VAGNE M,et al. A gastrin releasing peptide from the porcine non-antral gastric tissue[J]. Gut,1978, 19(9):767.

[4]

YAMAGUCHI K, ABE K, KAMEYA, T, et al. Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors[J]. Cancer Res,1983(43):3932.

[5]

MIYAKE Y,KODAMA T,YAMAGUCHI K. Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma[J]. Cancer Res,1994(54):2136.

[6]

邵良荣,邵杰,肖丽华,等. 联合检测血清四种肿瘤标志物对肺癌的诊断价值[J]. 中国实用医刊,2011,38(1):22.

[7]

SCHNEIDER J, PHILIPP M, SALEWSKI L, et al. Progastrin-releasing peptide(ProGRP) and neuron specific enolase(NSE) in therapy control of patients with small-cell lung cancer[J]. Clin Lab,2003,49(1/2):35.

[8]

TANG JH,ZHANG XL,ZHANG ZH,et al. Diagnostic value of tumor marker pro-gastrin-releasing peptide in patients with small cell lung cancer:a systematic review[J]. Chin Med J(Engl), 2011,124(10):1563.

[9]

KIM HR,Oh IJ,SHIN MG,et al. Plasma proGRP concentration is sensitive and specific for discriminating small cell lung cancer from nonmalignant conditions or non-small cell lung cancer[J]. J Korean Med Sci,2011,26(5):625.